Literature DB >> 14502277

Identification of PDGFR as a receptor for AAV-5 transduction.

Giovanni Di Pasquale1, Beverly L Davidson, Colleen S Stein, Inês Martins, Dominic Scudiero, Anne Monks, John A Chiorini.   

Abstract

Understanding the process of vector transduction has important implications for the application and optimal use of a vector system for human gene therapy. Recent studies with vectors based on adeno-associated virus type 5 (AAV-5) have shown utility of this vector system in the lung, central nervous system, muscle and eye. To understand the natural tropism of this virus and to identify proteins necessary for AAV-5 transduction, we characterized 43 cell lines as permissive or nonpermissive for AAV-5 transduction and compared the gene expression profiles derived from cDNA microarray analyses of those cell lines. A statistically significant correlation was observed between expression of the platelet-derived growth factor receptor (PDGFR-alpha-polypeptide) and AAV-5 transduction. Subsequent experiments confirmed the role of PDGFR-alpha and PDGFR-beta as receptors for AAV-5. The tropism of AAV-5 in vivo also correlated with the expression pattern of PDGFR-alpha.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14502277     DOI: 10.1038/nm929

Source DB:  PubMed          Journal:  Nat Med        ISSN: 1078-8956            Impact factor:   53.440


  131 in total

Review 1.  Pathways of cell infection by parvoviruses and adeno-associated viruses.

Authors:  Maija Vihinen-Ranta; Sanna Suikkanen; Colin R Parrish
Journal:  J Virol       Date:  2004-07       Impact factor: 5.103

2.  Examining the cross-reactivity and neutralization mechanisms of a panel of mAbs against adeno-associated virus serotypes 1 and 5.

Authors:  Carole E Harbison; Wendy S Weichert; Brittney L Gurda; John A Chiorini; Mavis Agbandje-McKenna; Colin R Parrish
Journal:  J Gen Virol       Date:  2011-11-09       Impact factor: 3.891

Review 3.  Adeno-associated Virus as a Mammalian DNA Vector.

Authors:  Max Salganik; Matthew L Hirsch; Richard Jude Samulski
Journal:  Microbiol Spectr       Date:  2015-08

Review 4.  The AAV vector toolkit: poised at the clinical crossroads.

Authors:  Aravind Asokan; David V Schaffer; R Jude Samulski
Journal:  Mol Ther       Date:  2012-01-24       Impact factor: 11.454

5.  The 37/67-kilodalton laminin receptor is a receptor for adeno-associated virus serotypes 8, 2, 3, and 9.

Authors:  Bassel Akache; Dirk Grimm; Kusum Pandey; Stephen R Yant; Hui Xu; Mark A Kay
Journal:  J Virol       Date:  2006-10       Impact factor: 5.103

6.  Alpha2,3 and alpha2,6 N-linked sialic acids facilitate efficient binding and transduction by adeno-associated virus types 1 and 6.

Authors:  Zhijian Wu; Edward Miller; Mavis Agbandje-McKenna; Richard Jude Samulski
Journal:  J Virol       Date:  2006-09       Impact factor: 5.103

7.  Adeno-associated virus type 2 contains an integrin alpha5beta1 binding domain essential for viral cell entry.

Authors:  Aravind Asokan; Julie B Hamra; Lakshmanan Govindasamy; Mavis Agbandje-McKenna; Richard J Samulski
Journal:  J Virol       Date:  2006-09       Impact factor: 5.103

8.  Efficient transduction of vascular endothelial cells with recombinant adeno-associated virus serotype 1 and 5 vectors.

Authors:  Sifeng Chen; Matthias Kapturczak; Scott A Loiler; Sergei Zolotukhin; Olena Y Glushakova; Kirsten M Madsen; Richard J Samulski; William W Hauswirth; Martha Campbell-Thompson; Kenneth I Berns; Terence R Flotte; Mark A Atkinson; C Craig Tisher; Anupam Agarwal
Journal:  Hum Gene Ther       Date:  2005-02       Impact factor: 5.695

9.  Host and vector-dependent effects on the risk of germline transmission of AAV vectors.

Authors:  Patricia Favaro; Harre D Downey; J Shangzhen Zhou; J Fraser Wright; Bernd Hauck; Federico Mingozzi; Katherine A High; Valder R Arruda
Journal:  Mol Ther       Date:  2009-03-17       Impact factor: 11.454

10.  Comparative transduction efficiency of AAV vector serotypes 1-6 in the substantia nigra and striatum of the primate brain.

Authors:  Eleni A Markakis; Kenneth P Vives; Jeremy Bober; Stefan Leichtle; Csaba Leranth; Jeff Beecham; John D Elsworth; Robert H Roth; R Jude Samulski; D Eugene Redmond
Journal:  Mol Ther       Date:  2009-12-15       Impact factor: 11.454

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.